Cingulate Inc (NASDAQ: CING) soared on Monday morning after the US Patent and Trademark Office (USPTO) cleared a key patent ...
Cingulate Inc. shares surged 30.7% amid strong investor interest in its ADHD treatment technology. Trading volume was high, with 3.297 million shares traded, reflecting growing market attention. Don’t ...
CING READ THE FULL CING RESEARCH REPORT Cingulate, Inc. (NASDAQ: CING) reported 2025 results on March 18 th , 2026. The ...
Cingulate, Inc. (NASDAQ:CING) reported third quarter 2025 results on November 13 th, 2025. No revenues were recorded and operating expense totaled $6.0 million. The new drug application (NDA) to the ...
Cingulate Inc (NASDAQ:CING) announced topline results from its Phase 3 adult trial of its lead candidate, CTx-1301 (dexmethylphenidate) for attention-deficit ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
The story of developer Cing is just about as morose as their cult hit adventure title, Hotel Dusk: Room 215. Signed on to develop with Nintendo, Cing released several interesting games, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results